Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $1.3 billion.

  • Bristol Myers Squibb's Dividends Paid - Common rose 361.25% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.0 billion, marking a year-over-year increase of 374.25%. This contributed to the annual value of $5.0 billion for FY2025, which is 374.25% up from last year.
  • Per Bristol Myers Squibb's latest filing, its Dividends Paid - Common stood at $1.3 billion for Q4 2025, which was up 361.25% from $1.3 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Dividends Paid - Common ranged from a high of $1.3 billion in Q3 2025 and a low of $8.0 million during Q2 2021
  • Its 5-year average for Dividends Paid - Common is $1.1 billion, with a median of $1.2 billion in 2023.
  • Its Dividends Paid - Common has fluctuated over the past 5 years, first plummeted by 9921.65% in 2021, then soared by 987500.0% in 2023.
  • Over the past 5 years, Bristol Myers Squibb's Dividends Paid - Common (Quarter) stood at $1.1 billion in 2021, then increased by 4.19% to $1.1 billion in 2022, then grew by 1.31% to $1.2 billion in 2023, then increased by 5.0% to $1.2 billion in 2024, then rose by 3.61% to $1.3 billion in 2025.
  • Its Dividends Paid - Common was $1.3 billion in Q4 2025, compared to $1.3 billion in Q3 2025 and $1.3 billion in Q2 2025.